December 10, 2021
IN8bio Promotes Kate Rochlin, Ph.D. to Chief Operating Officer
NEW YORK, Dec. 09, 2021 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery…
Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK, Dec. 09, 2021 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery…
NEW HAVEN, Conn., Dec. 09, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical…
Initiated and completed dosing in pharmacokinetic (PK) study of mavacamten in healthy Chinese volunteers Initiated Phase 2a clinical trial of…
— Angion to host a conference call today at 4:30 p.m. EST UNIONDALE, N.Y. and ST. GALLEN, Switzerland, Dec. 09,…
Data from preclinical studies in collaboration with Fred Hutchinson Cancer Research Center will be presented at ASH and provide strong…
DUBLIN, Ireland and BOSTON, Mass., Dec. 09, 2021 (GLOBE NEWSWIRE) — Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing…
TryptageniX will research and develop new sustainable methods of manufacturing therapeutic compounds commercially with increased reproducibility and reliability for clinical…
SAN DIEGO, Dec. 08, 2021 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the…
New England Journal of Medicine publishes positive Phase 3 Dupixent® (dupilumab) results in children with moderate-to-severe asthma Dupixent significantly reduced…
For the Second Year in Row, CB Insights Recognizes BrightInsight for its Leading Global Platform for Biopharma and Medtech Regulated…